+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Head And Neck Cancer"

From
From
From
From
From
From
Immuno-oncology Development Trends and Opportunities - Product Thumbnail Image

Immuno-oncology Development Trends and Opportunities

  • Report
  • November 2018
  • 258 Pages
  • Global
From
Disease Analysis: Head and Neck Cancer - Product Thumbnail Image

Disease Analysis: Head and Neck Cancer

  • Report
  • March 2021
  • 77 Pages
  • Global
From
2019 Post European Society for Medical Oncology (ESMO) Report - Product Thumbnail Image

2019 Post European Society for Medical Oncology (ESMO) Report

  • Report
  • October 2019
  • 117 Pages
  • Europe
From
Global Cancer Cachexia Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Cancer Cachexia Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Loading Indicator

Head and neck cancer is a type of cancer that affects the head and neck region, including the mouth, throat, nose, and salivary glands. It is a subset of oncology, the branch of medicine that deals with the diagnosis and treatment of cancer. Treatment for head and neck cancer typically involves surgery, radiation therapy, and chemotherapy. Depending on the type and stage of the cancer, a combination of these treatments may be used. Head and neck cancer is a growing area of oncology, with new treatments and technologies being developed to improve outcomes for patients. Research is ongoing to better understand the causes of head and neck cancer and to develop more effective treatments. Companies in the head and neck cancer market include AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer, Roche, and Sanofi. Show Less Read more